SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,320,560 | +167.0% | 35,642 | +152.3% | 0.00% | +100.0% |
| Q2 2023 | $1,617,973 | +6.5% | 14,128 | +28.2% | 0.00% | 0.0% |
| Q1 2023 | $1,518,928 | +57.4% | 11,020 | +48.0% | 0.00% | – |
| Q4 2022 | $964,892 | +40.7% | 7,446 | +20.0% | 0.00% | – |
| Q3 2022 | $686,000 | +198.3% | 6,206 | +102.7% | 0.00% | – |
| Q2 2022 | $230,000 | -3.8% | 3,062 | -0.1% | 0.00% | – |
| Q1 2022 | $239,000 | -21.9% | 3,064 | -9.7% | 0.00% | – |
| Q4 2021 | $306,000 | -24.8% | 3,393 | -22.8% | 0.00% | – |
| Q3 2021 | $407,000 | +48.5% | 4,397 | +24.8% | 0.00% | – |
| Q2 2021 | $274,000 | -29.6% | 3,523 | -32.5% | 0.00% | – |
| Q1 2021 | $389,000 | -75.5% | 5,217 | -43.9% | 0.00% | -100.0% |
| Q4 2020 | $1,586,000 | +22.9% | 9,300 | +1.3% | 0.00% | 0.0% |
| Q3 2020 | $1,290,000 | +131.2% | 9,185 | +164.2% | 0.00% | 0.0% |
| Q2 2020 | $558,000 | +63.2% | 3,477 | -0.5% | 0.00% | – |
| Q1 2020 | $342,000 | -19.7% | 3,495 | +5.9% | 0.00% | – |
| Q4 2019 | $426,000 | +40.6% | 3,299 | -18.0% | 0.00% | – |
| Q3 2019 | $303,000 | -33.3% | 4,024 | +34.6% | 0.00% | -100.0% |
| Q2 2019 | $454,000 | +5.3% | 2,990 | -17.3% | 0.00% | 0.0% |
| Q1 2019 | $431,000 | +28.3% | 3,616 | +17.4% | 0.00% | 0.0% |
| Q4 2018 | $336,000 | +148.9% | 3,081 | +201.8% | 0.00% | – |
| Q2 2018 | $135,000 | +80.0% | 1,021 | +1.3% | 0.00% | – |
| Q1 2018 | $75,000 | +23.0% | 1,008 | -7.5% | 0.00% | – |
| Q4 2017 | $61,000 | +29.8% | 1,090 | +5.8% | 0.00% | – |
| Q3 2017 | $47,000 | +135.0% | 1,030 | +80.4% | 0.00% | – |
| Q2 2017 | $20,000 | +53.8% | 571 | +38.3% | 0.00% | – |
| Q1 2017 | $13,000 | -18.8% | 413 | -28.2% | 0.00% | – |
| Q4 2016 | $16,000 | – | 575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |